Stanley Hsia to Humans
This is a "connection" page, showing publications Stanley Hsia has written about Humans.
Connection Strength
0.538
-
Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
Score: 0.075
-
Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States. J Clin Lipidol. 2013 Nov-Dec; 7(6):675-82.
Score: 0.048
-
Psychological insulin resistance among low-income, U.S. racial minority patients with type 2 diabetes. Prim Care Diabetes. 2013 Apr; 7(1):51-5.
Score: 0.047
-
Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
Score: 0.043
-
Insulin glargine compared to NPH among insulin-naïve, U.S. inner city, ethnic minority type 2 diabetic patients. Diabetes Res Clin Pract. 2011 Mar; 91(3):293-9.
Score: 0.041
-
A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. Am J Cardiol. 2006 Oct 15; 98(8):1047-52.
Score: 0.030
-
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med. 2025 Sep 18; 393(11):1065-1076.
Score: 0.028
-
Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
Score: 0.026
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study. Lancet. 2023 08 05; 402(10400):472-483.
Score: 0.024
-
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nat Med. 2023 02; 29(2):392-400.
Score: 0.024
-
Non-HDL cholesterol: into the spotlight. Diabetes Care. 2003 Jan; 26(1):240-2.
Score: 0.023
-
Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.
Score: 0.022
-
Modern pharmacotherapies for type 2 diabetes mellitus. J Natl Med Assoc. 2001 Sep; 93(9):335-48; quiz 348-9.
Score: 0.021
-
Efficacy and safety of dulaglutide 3.0?and 4.5?mg in patients aged?younger than?65 and?65?years or older: Post hoc analysis of the AWARD-11 trial. Diabetes Obes Metab. 2021 10; 23(10):2279-2288.
Score: 0.021
-
Results of a Study Comparing Glycated Albumin to Other Glycemic Indices. J Clin Endocrinol Metab. 2020 03 01; 105(3).
Score: 0.019
-
A Racial Comparison of Differences between Self-Reported and Objectively Measured Physical Activity among US Adults with Diabetes. Ethn Dis. 2017; 27(4):403-410.
Score: 0.017
-
The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012 Jul; 23(7):334-42.
Score: 0.011
-
Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss. Fertil Steril. 2006 Jun; 85(6):1794-802.
Score: 0.007
-
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002 Jan; 87(1):136-43.
Score: 0.005
-
Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res. 2000 May-Jun; 20(3A):1391-414.
Score: 0.005